Scientific Writing (2)

Thank you for the story "What's right about scientific writing" by Gross and Harmon.1 They've done a great job. The story presented in a conventional scientific paper does not follow the historical sequence of how ideas developed while the experimental work proceeded. But that does not matter; it is more important that the paper aids the reader in understanding the ideas being presented. However, I regret that these authors did not deal with some associated problems of the science paper. I

Written byPeter Meredith
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Thank you for the story "What's right about scientific writing" by Gross and Harmon.1 They've done a great job. The story presented in a conventional scientific paper does not follow the historical sequence of how ideas developed while the experimental work proceeded. But that does not matter; it is more important that the paper aids the reader in understanding the ideas being presented.

However, I regret that these authors did not deal with some associated problems of the science paper. Its production can be such a wasteful process, running the gauntlet of semicompetent editing (in poorer quality publications, of course), dangerous peer-reviewing, and, in many organizations, very time-consuming internal reviewing that all too often turns out to be at odds with the external reviewers.

I have written on this subject,2 but it aroused little publicity. I suspect that many scientists are not in a position to criticize the peer-review system ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies